Skip to content

3T_the 10000 Tendons study

3T_the 10000 Tendons study: outcome prediction for 5 tendinopathies: an international cohort study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ISRCTN
Registry ID
ISRCTN57409668
Enrollment
9999
Registered
2020-01-10
Start date
2019-12-01
Completion date
Unknown
Last updated
2020-01-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tendinopathy Musculoskeletal Diseases Enthesopathy, unspecified

Interventions

Patients will be identified by clinicians at recruiting organisations and contact details sent, via a secure SmartTrial contact form to the researchers who will respond with a link to the correct data

Sponsors

QMUL
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: For all conditions to be studied AT, GT, PT, PHP, ST these inclusion criteria are the same: 1. Aged 18 and over 2. Having Achilles, gluteal, patellar, rotator cuff tendinopathy or plantar heel pain diagnosed by a relevant clinician (for the condition specific group) 3. Having other posterior calf, hip, foot, knee, shoulder diagnoses (for the ‘other pathology’ groups) 4. Healthy volunteers without any current foot and ankle, hip, knee, shoulder problems in the last six months (for the control group) Specific inclusion criteria for PT: 1. Performing a jumping related sport such as volleyball, basketball, netball, athletics, football, handball, sprinting 2. Having a regular sports training schedule

Exclusion criteria

Exclusion criteria: Does not meet inclusion criteria

Design outcomes

Primary

MeasureTime frame
Symptoms/change in pain is measured using the global rating of change every four weeks via questionnaires on SmartTrial (every three weeks for knee), for 12 months. Except for the control group who are asked if they have any new symptoms/pain

Secondary

MeasureTime frame
1. Symptoms/change in pain is measured using the patient acceptable symptom state (PASS) every four weeks via questionnaires on SmartTrial (every three weeks for knee), for 12 months. Except for the control group who are asked if they have any new symptoms/pain 2. Symptoms/change in pain is measured using the single assessment numeric evaluation (SANE) every four weeks via questionnaires on SmartTrial (every three weeks for knee), for 12 months. Except for the control group who are asked if they have any new symptoms/pain

Countries

United Kingdom

Contacts

Public ContactDylan Morrissey
d.morrissey@qmul.ac.uk+44 (0)7941710273

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026